Identity & Authority: GAZYVA (Genentech) – Signal Evidence & AI Readability

GAZYVA (Genentech)

(https://gazyva.com) 📸 Data Snapshot: May 30, 2026
Identity & Authority — The Lens

Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.

Identity & Authority Expert verifiability & Schema depth.
15 Impact Weight: 15 / 100
100% Reputation

Authority is well-established through correct Organization schema for Genentech and MedicalWebPage schema on deep pages. There are no expert claims without footprint as the site relies on the corporate brand and clinical regulatory approval rather than individual named experts. Technical implementation is clean with established structured data.

The marketing tone is generally sober, though phrases like seize the opportunity lean toward a promotional tone that slightly disconnects from the clinical risk profile described. Most performance claims are directly tied to FDA-approved indications rather than vague breakthroughs. The primary disconnect is the lack of visible evidence (case studies or data visualizations) in the clean text to back up the claim GAZYVA works to break down cancer cells quickly.

Identity & Authority is read from the structured data first: whether the site declares who it is in machine-readable schema, with verifiable identity links. Below is the schema captured per page, then the external proof links that support (or fail to support) that identity.

🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps
Homepage schema
{
    "@context": "http://schema.org",
    "@type": "Organization",
    "name": "Genentech",
    "url": "https://www.gene.com/",
    "logo": "https://www.gene.com/assets/frontend/img/Genentech_logo.png",
    "description": "Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases.",
    "contactPoint": {
        "@type": "ContactPoint",
        "telephone": "+1-877-436-3683",
        "contactType": "customer service"
    },
    "address": {
        "@type": "PostalAddress",
        "streetAddress": "1 DNA Way",
        "addressLocality": "South San Francisco",
        "addressRegion": "California",
        "postalCode": "94080",
        "addressCountry": "US"
    }
}
/safety.html
{
    "@context": "http://schema.org",
    "@type": "Organization",
    "name": "Genentech",
    "url": "https://www.gene.com/",
    "logo": "https://www.gene.com/assets/frontend/img/Genentech_logo.png",
    "description": "Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases.",
    "contactPoint": {
        "@type": "ContactPoint",
        "telephone": "+1-877-436-3683",
        "contactType": "customer service"
    },
    "address": {
        "@type": "PostalAddress",
        "streetAddress": "1 DNA Way",
        "addressLocality": "South San Francisco",
        "addressRegion": "California",
        "postalCode": "94080",
        "addressCountry": "US"
    }
}
/lupus-nephritis.html
[
    {
        "@context": "http://schema.org",
        "@type": "Organization",
        "name": "Genentech",
        "url": "https://www.gene.com/",
        "logo": "https://www.gene.com/assets/frontend/img/Genentech_logo.png",
        "description": "Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases.",
        "contactPoint": {
            "@type": "ContactPoint",
            "telephone": "+1-877-436-3683",
            "contactType": "customer service"
        },
        "address": {
            "@type": "PostalAddress",
            "streetAddress": "1 DNA Way",
            "addressLocality": "South San Francisco",
            "addressRegion": "California",
            "postalCode": "94080",
            "addressCountry": "US"
        }
    },
    {
        "@context": "schema.org",
        "@type": "MedicalWebPage",
        "url": "https://www.gazyva.com/lupus-nephritis.html",
        "description": "Learn about GAZYVA® (obinutuzumab), a biologic treatment that your doctor may prescribe for lupus nephritis. See Important Safety Information including Serious Side Effects for more information.",
        "MedicalAudience": "https://schema.org/Patient",
        "about": [
            {
                "@type": "Drug",
                "name": "GAZYVA®",
                "nonProprietaryName": "obinutuzumab",
                "dosageForm": [
                    "infusion"
                ],
                "administrationRoute": [
                    "iv"
                ]
            },
            {
                "@type": "MedicalCondition",
                "name": "lupus nephritis (LN)",
                "alternateName": [
                    "LN"
                ]
            }
        ]
    }
]
/first-line-fl.html
{
    "@context": "http://schema.org",
    "@type": "Organization",
    "name": "Genentech",
    "url": "https://www.gene.com/",
    "logo": "https://www.gene.com/assets/frontend/img/Genentech_logo.png",
    "description": "Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases.",
    "contactPoint": {
        "@type": "ContactPoint",
        "telephone": "+1-877-436-3683",
        "contactType": "customer service"
    },
    "address": {
        "@type": "PostalAddress",
        "streetAddress": "1 DNA Way",
        "addressLocality": "South San Francisco",
        "addressRegion": "California",
        "postalCode": "94080",
        "addressCountry": "US"
    }
}
🛡️ Trust Signals — external proof links that back the declared identity
4Review mentions (all pages)
0External proof links (all pages)
PageReviewsProof links
/ (home) 1 0
/safety.html 1 0
/lupus-nephritis.html 1 0
/first-line-fl.html 1 0